These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3317527)

  • 41. Evidence for co-transmitter role of neuropeptide Y in the pig spleen.
    Lundberg JM; Rudehill A; Sollevi A; Hamberger B
    Br J Pharmacol; 1989 Mar; 96(3):675-87. PubMed ID: 2566349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular, neuropeptide Y, and adrenergic responses in stress are sexually differentiated.
    Zukowska-Grojec Z; Shen GH; Capraro PA; Vaz CA
    Physiol Behav; 1991 Apr; 49(4):771-7. PubMed ID: 1881983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma neuropeptide Y (NPY) and galanin before and during exercise in type 1 diabetic patients with autonomic dysfunction.
    Sundkvist G; Bramnert M; Bergström B; Manhem P; Lilja B; Ahrén B
    Diabetes Res Clin Pract; 1992 Mar; 15(3):219-26. PubMed ID: 1374311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia.
    Kaijser L; Pernow J; Berglund B; Lundberg JM
    Clin Physiol; 1990 Mar; 10(2):179-88. PubMed ID: 2318028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Splanchnic release of neuropeptide Y during prolonged exercise with and without beta-adrenoceptor blockade in healthy man.
    Ahlborg G; Lundberg JM
    Clin Physiol; 1991 Jul; 11(4):343-51. PubMed ID: 1680600
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropeptide Y in multiple endocrine neoplasia: release during surgery for phaeochromocytoma.
    Connell JM; Corder R; Asbury J; Macpherson S; Inglis GC; Lowry P; Burt AD; Semple PF
    Clin Endocrinol (Oxf); 1987 Jan; 26(1):75-84. PubMed ID: 2879655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.
    Dubois-Randé JL; Comoy E; Merlet P; Benvenuti C; Carville C; Hittinger L; Macquin-Mavier I; Bohuon C; Castaigne A
    Eur Heart J; 1992 Sep; 13(9):1233-8. PubMed ID: 1396834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age-related bidirectional changes in neuropeptide Y peptides in rat adrenal glands, brain, and blood.
    Higuchi H; Yang HY; Costa E
    J Neurochem; 1988 Jun; 50(6):1879-86. PubMed ID: 3373217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of shosaikoto on plasma catecholamines.
    Amagaya S; Ogihara Y
    J Ethnopharmacol; 1989 Oct; 26(3):271-6. PubMed ID: 2615407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sympathoadrenal responses to bronchoconstriction in asthma: an invasive and kinetic study of plasma catecholamines.
    Larsson K; Carlens P; Bevegård S; Hjemdahl P
    Clin Sci (Lond); 1995 Apr; 88(4):439-46. PubMed ID: 7789046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma levels of neuropeptide tyrosine Y (NPY) are increased in human sepsis but are unchanged during canine endotoxin shock despite raised catecholamine concentrations.
    Watson JD; Sury MR; Corder R; Carson R; Bouloux PM; Lowry PJ; Besser GM; Hinds CJ
    J Endocrinol; 1988 Mar; 116(3):421-6. PubMed ID: 3351430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission.
    Linton-Dahlöf P
    Acta Physiol Scand Suppl; 1989; 586():1-85. PubMed ID: 2557726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report.
    Morgan CA; Rasmusson AM; Wang S; Hoyt G; Hauger RL; Hazlett G
    Biol Psychiatry; 2002 Jul; 52(2):136-42. PubMed ID: 12114005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exposure to acute physical and psychological stress alters the response of rat macrophages to corticosterone, neuropeptide Y and beta-endorphin.
    Stanojević S; Mitić K; Vujić V; Kovacević-Jovanović V; Dimitrijević M
    Stress; 2007 Mar; 10(1):65-73. PubMed ID: 17454968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE; Lundberg JN; Weitzberg E
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man.
    Pernow J; Lundberg JM; Kaijser L
    Life Sci; 1987 Jan; 40(1):47-54. PubMed ID: 3796213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of neuropeptide Y injected into A1 noradrenergic nucleus on blood pressure and catecholamines in plasma of cats.
    Yang SN; Tang YH; Yang XL; Wang S
    Zhongguo Yao Li Xue Bao; 1992 Sep; 13(5):400-2. PubMed ID: 1300039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats.
    Kvetnanský R; Fukuhara K; Pacák K; Cizza G; Goldstein DS; Kopin IJ
    Endocrinology; 1993 Sep; 133(3):1411-9. PubMed ID: 8396019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.
    Hetland ML; Eldrup E; Bratholm P; Christensen NJ
    Scand J Clin Lab Invest; 1991 May; 51(3):219-24. PubMed ID: 1909048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.